Brian Kerrane
About Brian Kerrane
Brian Kerrane (born 1969) is Chief Operating Officer of Neuberger Berman High Yield Strategies Fund Inc. (NHS) and related Neuberger Berman closed‑end funds, serving as COO since 2015 and Vice President since 2008; he has been a Managing Director at Neuberger Berman since 2013 and an employee since 1991 . He also serves as COO of ten registered investment companies and Vice President of twenty‑eight registered investment companies within the Neuberger Berman complex, reflecting broad operating responsibility across the fund family . Officers who are employees of Neuberger Berman Investment Advisers LLC (NBIA) serve the Funds without compensation from the Funds, and officer terms are at the pleasure of the Boards per the Funds’ bylaws . The proxy does not disclose education or fund‑level TSR/revenue/EBITDA metrics tied to Mr. Kerrane’s role .
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| NBIA / Neuberger Berman | Senior Vice President, Neuberger Berman | 2006–2014 | Senior leadership within the adviser supporting mutual fund operations . |
| NBIA | Vice President | 2008–2015 | Expanded operating responsibilities within the fund complex . |
| NBIA / Neuberger Berman | Managing Director | Since 2013 | Senior executive capacity across the registered funds platform . |
| Neuberger Berman Funds (multiple) | Chief Operating Officer (10 registered funds) | Since 2015 | Day‑to‑day operational oversight across the complexes’ closed‑end funds . |
| Neuberger Berman Funds (multiple) | Vice President (28 registered funds) | Ongoing | Officer capacity across broader NB fund family . |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| Neuberger Berman BD LLC (affiliate) | Managing Director | Ongoing | Listed in NBIA regulatory disclosure of business and other connections . |
Fixed Compensation
| Component | Amount/Terms | Notes |
|---|---|---|
| Compensation from NHS/NB closed‑end funds | $0 | Officers employed by NBIA serve without any compensation from the Funds; compensation, if any, is paid by NBIA and not disclosed in the Fund proxy . |
| Term of office | Indefinite; officers serve at the pleasure of the Directors | Officers hold office until a successor is elected and qualified or earlier death, inability to serve, or resignation; may be removed at any time with or without cause . |
Performance Compensation
- Not disclosed. The proxy does not provide base salary, bonus targets/outcomes, equity awards (RSUs/PSUs/options), or performance metrics for Mr. Kerrane; officers who are NBIA employees are not compensated by the Funds, and NBIA compensation practices are not detailed in the Fund proxy .
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Beneficial ownership in NHS | Not disclosed for officers; proxy presents equity ownership only for Directors and shows “None” for NHS across Independent Directors as of July 31, 2025 . |
| Shares pledged/hedged | Not disclosed in proxy for officers . |
| Ownership guidelines | Not disclosed for officers in the Fund proxy . |
Employment Terms
- Appointment and removal: Officers are appointed by the Directors; each officer serves until a successor is elected and qualified or earlier death/inability/resignation, and may be removed at any time with or without cause .
- Employer of record: NBIA (adviser). Officers who are employees of NBIA serve without compensation from the Funds; any employment contracts, severance, or change‑of‑control provisions would be with NBIA and are not disclosed in the Fund proxy .
- Business address: 1290 Avenue of the Americas, New York, NY 10104 .
Investment Implications
- Compensation alignment and disclosure: As an NBIA employee, Mr. Kerrane’s compensation is not paid by NHS and is not disclosed in Fund filings, limiting visibility into pay‑for‑performance linkages; this is standard for externally managed closed‑end funds and reduces direct fund‑level compensation conflicts, but also limits investor insight into incentive structures .
- Retention risk: Officer terms are at the pleasure of the Boards, with employment governed by NBIA; severance/CIC economics are not disclosed at the Fund level, so retention risk must be assessed at the adviser rather than the Fund .
- Ownership/pledging: No officer ownership or pledging disclosures are provided for NHS, and the Director ownership table shows no NHS holdings among Independent Directors as of July 31, 2025; lack of officer ownership disclosure limits “skin‑in‑the‑game” assessment at the Fund level .
- Execution scope: Mr. Kerrane’s multi‑fund COO remit across ten registered funds and VP roles across twenty‑eight funds underscore operational influence within the Neuberger Berman fund complex, a potential positive for process consistency and risk management across the platform .